Leading manufacturer of dental implants, abutments, and related products selects clinivation’s Global Market Clearance Services to position their operations for continued growth and successful expansion.
Natick, MA, August 13, 2008 – clinivation, Inc. announced today that BIOMET 3i has selected the clinivation’s Global Market Clearance Services
“BIOMET 3i is a world leader in the development, manufacture, and distribution of oral reconstructive products, and we are pleased that they have selected clinivation’s Global Market Clearance Services to position their operations for continued growth and successful expansion,” said Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions.
About clinivation’s Global Market Clearance Services
Clinivation’s Global Market Clearance services leverage our excellence in market clearance and many years of focused, successful experience in developing and supporting thousands of medtech market clearance applications in all of the major and emerging world markets. Our many years of successful experience spans from comprehensive initiation, support, and execution of the most complex Class III PMA programs to focused global market clearance initiatives.
About BIOMET 3i
Headquartered in Palm Beach Gardens, Florida, with operations throughout the world, BIOMET 3i is one of the world’s leading companies in the oral reconstruction market. BIOMET 3i offers one of implant dentistry’s most comprehensive lines of implants and abutments, augmented by a growing line of site preparation and regenerative products. BIOMET 3i pioneered the development of biologically driven implants, winning worldwide acclaim for the microtextured surface and superior clinical success rates of the OSSEOTITE® Implant.
Of equal importance, since its inception in 1987, BIOMET 3i has brought the same innovation, high standards, and comprehensive approach to customer service, practice and laboratory support and education.
For more information, please visit www.biomet3i.com
